SeaSpine Holdings Past Earnings Performance
Past criteria checks 0/6
Key information
-14.3%
Earnings growth rate
11.1%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 10.0% |
| Return on equity | -23.6% |
| Net Margin | -28.2% |
| Last Earnings Update | 30 Sep 2022 |
Recent past performance updates
Recent updates
SeaSpine Holdings (NASDAQ:SPNE) Has Debt But No Earnings; Should You Worry?
Sep 24
SeaSpine: Bottom Line Fundamentals Continue To Soften
Sep 22SeaSpine amends $30M credit facility
Jul 19SeaSpine: Lacks Equity Premium To Deliver Real Risk-Adjusted Return
Jul 08Is SeaSpine Holdings (NASDAQ:SPNE) Using Debt Sensibly?
Jun 07SeaSpine begins limited commercial launch of the waveform L 3d-printed interbody system
Jun 08It Looks Like The CEO Of SeaSpine Holdings Corporation (NASDAQ:SPNE) May Be Underpaid Compared To Peers
May 27SeaSpine EPS misses by $0.13, beats on revenue
May 03SeaSpine guides Q4 and FY2020 revenue below consensus
Jan 11SeaSpine Holdings: Waiting To See If It Can Straighten Up
Dec 22Did SeaSpine Holdings' (NASDAQ:SPNE) Share Price Deserve to Gain 61%?
Dec 07SeaSpine (SPNE) Investor Presentation - Slideshow
Nov 17SeaSpine EPS beats by $0.06, beats on revenue; updates Q4 revenue guidance
Nov 09Revenue & Expenses BreakdownBeta
Revenue & Expenses Breakdown
BetaHow SeaSpine Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 22 | 230 | -65 | 172 | 24 |
| 30 Jun 22 | 209 | -67 | 164 | 24 |
| 31 Mar 22 | 200 | -58 | 153 | 23 |
| 31 Dec 21 | 191 | -54 | 146 | 22 |
| 30 Sep 21 | 182 | -46 | 139 | 20 |
| 30 Jun 21 | 179 | -35 | 133 | 18 |
| 31 Mar 21 | 160 | -43 | 124 | 17 |
| 31 Dec 20 | 154 | -43 | 120 | 16 |
| 30 Sep 20 | 152 | -41 | 118 | 16 |
| 30 Jun 20 | 148 | -45 | 117 | 16 |
| 31 Mar 20 | 159 | -43 | 119 | 16 |
| 31 Dec 19 | 159 | -39 | 117 | 15 |
| 30 Sep 19 | 153 | -40 | 115 | 14 |
| 30 Jun 19 | 149 | -40 | 112 | 14 |
| 31 Mar 19 | 146 | -35 | 110 | 13 |
| 31 Dec 18 | 143 | -34 | 107 | 12 |
| 30 Sep 18 | 139 | -32 | 105 | 12 |
| 30 Jun 18 | 135 | -29 | 103 | 11 |
| 31 Mar 18 | 133 | -30 | 100 | 12 |
| 31 Dec 17 | 132 | -32 | 100 | 12 |
| 30 Sep 17 | 130 | -34 | 96 | 12 |
| 30 Jun 17 | 130 | -36 | 94 | 12 |
| 31 Mar 17 | 129 | -40 | 96 | 12 |
| 31 Dec 16 | 129 | -43 | 98 | 11 |
| 30 Sep 16 | 131 | -47 | 102 | 11 |
| 30 Jun 16 | 132 | -52 | 101 | 10 |
| 31 Mar 16 | 132 | -58 | 97 | 9 |
Quality Earnings: SPNE is currently unprofitable.
Growing Profit Margin: SPNE is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SPNE is unprofitable, and losses have increased over the past 5 years at a rate of 14.3% per year.
Accelerating Growth: Unable to compare SPNE's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SPNE is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-8.4%).
Return on Equity
High ROE: SPNE has a negative Return on Equity (-23.62%), as it is currently unprofitable.